Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by H M Kantajian
Differential Depth of Treatment Response Required for Optimal Outcome in Patients With Blast Phase Versus Chronic Phase of Chronic Myeloid Leukemia
Blood Cancer Journal
Oncology
Hematology
Related publications
Cost-Effectiveness of Ponatinib in the Treatment of Patients With Accelerated or Blast Phase - Chronic Myeloid Leukemia in Greece
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Chronic Myeloid Leukemia: Why Does It Evolve From Chronic Phase to Blast Transformation?
Frontiers in Bioscience - Landmark
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
Short Overview on the Current Treatment of Chronic Myeloid Leukemia in Chronic Phase
Memo - Magazine of European Medical Oncology
Oncology
Hematology
Management of Chronic Myeloid Leukemia in Advanced Phase
Frontiers in Oncology
Cancer Research
Oncology
Pleural Effusion in Dasatinib-Treated Patients With Chronic Myeloid Leukemia in Chronic Phase: Identification and Management
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
TKI-Related Platelet Dysfunction Does Not Correlate With Bleeding in Patients With Chronic Phase-Chronic Myeloid Leukemia With Complete Hematological Response
Clinical and Applied Thrombosis/Hemostasis
Medicine
Hematology
Complications of Tyrosine Kinase Inhibitors Therapy in Chronic Myeloid Leukemia - Chronic Phase
Revista de Chimie
Surfaces
Materials Science
Engineering
Materials Chemistry
Films
Coatings
Chemistry
Tyrosine Kinase Inhibitors as Initial Therapy for Patients With Chronic Myeloid Leukemia in Accelerated Phase
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Influence of CYP3A5 and Drug Transporter Polymorphisms on Imatinib Trough Concentration and Clinical Response Among Patients With Chronic Phase Chronic Myeloid Leukemia
Journal of Human Genetics
Genetics
